Cargando…
Protective Effect of CXCR4 Antagonist CX807 in a Rat Model of Hemorrhagic Stroke
Intracerebral hemorrhage (ICH) is a major cause of stroke, with high mortality and morbidity. There is no effective pharmacological therapy for ICH. Previous studies have indicated that CXCR4 antagonists reduced microglia activation, attenuated infiltration of T cells, and improved functional recove...
Autores principales: | Yu, Seong-Jin, Wu, Kuo-Jen, Wang, Yu-Syuan, Song, Jen-Shin, Wu, Chien-Huang, Jan, Jiing-Jyh, Bae, Eunkyung, Chen, Hsi, Shia, Kak-Shan, Wang, Yun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7582767/ https://www.ncbi.nlm.nih.gov/pubmed/32992950 http://dx.doi.org/10.3390/ijms21197085 |
Ejemplares similares
-
Protective Effect of CXCR4 Antagonist DBPR807 against Ischemia-Reperfusion Injury in a Rat and Porcine Model of Myocardial Infarction: Potential Adjunctive Therapy for Percutaneous Coronary Intervention
por: Yeh, Kai-Chia, et al.
Publicado: (2022) -
A highly selective and potent CXCR4 antagonist for hepatocellular carcinoma treatment
por: Song, Jen-Shin, et al.
Publicado: (2021) -
At R807
Publicado: (1978) -
At R807
Publicado: (1980) -
Human Milk Oligosaccharide 2′-Fucosyllactose Induces Neuroprotection from Intracerebral Hemorrhage Stroke
por: Hung, Tsai-Wei, et al.
Publicado: (2021)